Esophageal Neoplasms Clinical Trials

170 clinical trials for Esophageal Neoplasms across international registries, including 24 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06) — RECRUITING · PHASE1
• A Study of LY4257496 in Participants With Cancer (OMNIRAY) — RECRUITING · PHASE1
• A Study of LY4337713 in Participants With FAP-Positive Solid Tumors — RECRUITING · PHASE1
• Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06) — RECRUITING · PHASE1
• Comparative Study Between (FC-SEMS) and (PC-SEMS) in the Palliation of Dysphagia Due to Malignant Neoplasm of Esophagus. — RECRUITING · NA
• Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic Resections — RECRUITING · NA
• Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer — RECRUITING
• A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer — RECRUITING · PHASE1
• Luso-Cor Stent Compared to Other Endoscopic Techniques for Management of Fistulas and Anastomotic Dehiscences(ES-LCCE-UDFM) — RECRUITING
• Mayo Clinic Upper Digestive Disease Survey — RECRUITING
• Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction Cancer — RECRUITING · NA
• Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer — RECRUITING · NA
• Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer — RECRUITING · NA
• Endoscopic Resection of Gastrointestinal Neoplasms — RECRUITING
• Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques — RECRUITING
• HTL0039732 in Participants With Advanced Solid Tumours — RECRUITING · PHASE1
• The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study — RECRUITING
• Fruquintinib in Combination With Tislelizumab Followed by Radiotherapy in Esophageal Squamous Cell Carcinoma — RECRUITING · PHASE2
• Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for Reliable Diagnostic RNA Plasma-based Biomarkers — RECRUITING
• PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer — RECRUITING · PHASE3
• Distribution of Lymph Node Metastases in Esophageal Carcinoma — RECRUITING
• Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer. — RECRUITING · PHASE2
• Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer — RECRUITING · NA
• Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients — RECRUITING · PHASE2
• Spatial MSC Index for Predicting Anti-PD-1 Efficacy in Esophageal Cancer — ACTIVE_NOT_RECRUITING
• Phase I Platinum Based Chemotherapy Plus Indomethacin — COMPLETED · PHASE1
• Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy — ACTIVE_NOT_RECRUITING · PHASE3
• A Clinical Study on the Effect of Massaging Tian Tu Acupoint on Coughing After Esophageal Surgery — NOT_YET_RECRUITING · NA
• Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial — COMPLETED · PHASE2
• PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer — COMPLETED · PHASE2
• Esophageal Cancer Multimodal Prehabilitation Study — COMPLETED · NA
• Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI — ACTIVE_NOT_RECRUITING · NA
• MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) — COMPLETED · PHASE2
• A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab — COMPLETED · PHASE1
• Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Cancer — TERMINATED · PHASE1
• OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma — COMPLETED · NA
• A Study of SGN-STNV in Advanced Solid Tumors — TERMINATED · PHASE1
• Automatic Diagnosis of Early Esophageal Squamous Neoplasia Using pCLE With AI — COMPLETED
• Tranilast Vs. Steroids to Prevent Esophageal Stricture (TAPES) After Endoscopic Resection for Superficial Neoplasms — NOT_YET_RECRUITING · PHASE2
• First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590) — COMPLETED · PHASE3
• The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage I — COMPLETED · PHASE3
• A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer — TERMINATED · PHASE2
• Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer — WITHDRAWN · PHASE1
• Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC) — OTHER
• A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma — COMPLETED
• Early Detection of Esophageal Cancer — TERMINATED
• Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer. — OTHER · NA
• Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans — OTHER · NA
• KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method) — COMPLETED
• Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction — COMPLETED · PHASE2

Refine this search